Agilent Receives Approval for GenetiSure Dx Postnatal Assay in Japan
The Pharma Data
DECEMBER 22, 2020
Available since 2017 as an in vitro diagnostic assay (IVD) in Europe and the United States, Japanese clinical geneticists can now have access to this assay to help identify a definitive genetic diagnosis for their patients. SANTA CLARA, Calif.–( –( BUSINESS WIRE )– Agilent Technologies Inc.
Let's personalize your content